Reliance Chemotex Valuation
RELCHEMQ | 210.99 1.25 0.59% |
At this time, the company appears to be overvalued. Reliance Chemotex holds a recent Real Value of USD178.89 per share. The prevailing price of the company is USD210.99. Our model determines the value of Reliance Chemotex from analyzing the company fundamentals such as Return On Equity of 0.0189, shares outstanding of 7.54 M, and Operating Margin of 0.07 % as well as examining its technical indicators and probability of bankruptcy.
Price Book 1.1854 | Enterprise Value 4 B | Enterprise Value Ebitda 13.3687 | Price Sales 0.4236 | Trailing PE 62.9792 |
Overvalued
Today
Please note that Reliance Chemotex's price fluctuation is very steady at this time. Calculation of the real value of Reliance Chemotex is based on 3 months time horizon. Increasing Reliance Chemotex's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Reliance stock is determined by what a typical buyer is willing to pay for full or partial control of Reliance Chemotex Industries. Since Reliance Chemotex is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Reliance Stock. However, Reliance Chemotex's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. Historical | Market 210.99 | Real 178.89 | Hype 210.99 |
The intrinsic value of Reliance Chemotex's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Reliance Chemotex's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Reliance Chemotex Industries helps investors to forecast how Reliance stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Reliance Chemotex more accurately as focusing exclusively on Reliance Chemotex's fundamentals will not take into account other important factors: Reliance Chemotex Cash |
|
Reliance Chemotex Total Value Analysis
Reliance Chemotex Industries is at this time forecasted to have takeover price of 3.95 B with market capitalization of 1.6 B, debt of 2.81 B, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Reliance Chemotex fundamentals before making investing decisions based on enterprise value of the companyTakeover Price | Market Cap | Debt Obligations | Cash |
3.95 B | 1.6 B | 2.81 B |
Reliance Chemotex Investor Information
About 75.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 1.19. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Reliance Chemotex last dividend was issued on the 4th of September 2024. Based on the key measurements obtained from Reliance Chemotex's financial statements, Reliance Chemotex Industries is not in a good financial situation at this time. It has a very high probability of going through financial hardship in February.Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
---|---|---|---|---|---|---|---|---|---|
Operating Income | 131.3 M | 240.7 M |
|
|
Reliance Chemotex Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Reliance Chemotex has an asset utilization ratio of 76.33 percent. This suggests that the Company is making USD0.76 for each dollar of assets. An increasing asset utilization means that Reliance Chemotex Industries is more efficient with each dollar of assets it utilizes for everyday operations.Reliance Chemotex Ownership Allocation
The market capitalization of Reliance Chemotex is USD1.6 Billion. Reliance Chemotex holds majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 75.21 pct. of Reliance Chemotex outstanding shares that are owned by insiders implies they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please take into account that even companies with profitable outlook can generate negative future returns on their equity. If the true value of the company is less than the current market value, you may not be able generate positive returns on investment in the long run.Reliance Chemotex Profitability Analysis
The company reported the revenue of 3.67 B. Net Income was 32.1 M with profit before overhead, payroll, taxes, and interest of 1.73 B.About Reliance Chemotex Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Reliance Chemotex Industries. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Reliance Chemotex based exclusively on its fundamental and basic technical indicators. By analyzing Reliance Chemotex's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Reliance Chemotex's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Reliance Chemotex. We calculate exposure to Reliance Chemotex's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Reliance Chemotex's related companies.Last Reported | Projected for Next Year | ||
Gross Profit | 2 B | 1.1 B |
Reliance Chemotex Quarterly Retained Earnings |
|
Other Information on Investing in Reliance Stock
Reliance Chemotex financial ratios help investors to determine whether Reliance Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Reliance with respect to the benefits of owning Reliance Chemotex security.